Bausch And Lomb Quick Ratio (BLCO) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Bausch and Lomb Corp  (NYSE: BLCO)

Bausch And Lomb's Quick Ratio

BLCO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Bausch And Lomb's Cash & cash equivalent grew by 39.78 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Bausch And Lomb's Quick Ratio to 0.25, above Bausch and Lomb Corp average Quick Ratio.

Within Medical Equipment & Supplies industry 172 other companies have achieved higher Quick Ratio than Bausch And Lomb in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 3147 to 3410.

Explain Quick Ratio?
How much Cash & cash equivalents BLCO´s has?
What are BLCO´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BLCO/financial-strength
https://api.csimarket.com/api/v1/companies/BLCO/fundamentals
https://api.csimarket.com/api/v1/companies/BLCO/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
BLCO Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 6.49 %
Y / Y Cash & cash equivalent Change 65.48 %
Quick Ratio MRQ 0.25
BLCO's Total Ranking # 3410
Seq. Current Liabilities Change 3.96 %
Seq. Cash & cash equivalent Change 39.78 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 173
Healthcare Sector # 825
Overall Market # 3410


Quick Ratio Statistics
High Average Low
0.34 0.2 0.12
(Jun 30 2022)   (Mar 31 2025)




Financial Statements
Bausch And Lomb's Current Liabilities $ 2,019 Millions Visit BLCO's Balance sheet
Bausch And Lomb's Cash & cash equivalent $ 513 Millions Visit BLCO's Balance sheet
Source of BLCO's Sales Visit BLCO's Sales by Geography


Cumulative Bausch And Lomb's Quick Ratio

BLCO's Quick Ratio for the trailling 12 Months

BLCO Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 6.96 %
Y / Y Cash & cash equivalent TTM Growth 41.37 %
Quick Ratio TTM 0.2
Total Ranking TTM # 4120
Seq. Current Liabilities TTM Growth 1.62 %
Seq. Cash & cash equivalent TTM Growth 15.29 %


On the trailing twelve months basis BLCO Cash & cash equivalent soared by 65.48 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Bausch And Lomb's Quick Ratio to 0.2, Quick Ratio remained below BLCO average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 206 other companies have achieved higher Quick Ratio than Bausch And Lomb. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3187 to 4120.

Explain Quick Ratio?
How much Cash & cash equivalents BLCO´s has?
What are BLCO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 207
Healthcare Sector # 912
Within the Market # 4120


trailing twelve months Quick Ratio Statistics
High Average Low
0.28 0.21 0.15
(Mar 31 2023)   (Sep 30 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Electrocore Inc   0.69 $ 7.506  Millions$ 10.866  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.69 $ 8.124  Millions$ 11.778  Millions
Sintx Technologies Inc   0.67 $ 2.005  Millions$ 3.004  Millions
Privia Health Group Inc   0.66 $ 446.283  Millions$ 674.358  Millions
Lensar Inc   0.64 $ 12.622  Millions$ 19.811  Millions
Orthofix Medical Inc   0.62 $ 86.322  Millions$ 138.385  Millions
Carlisle Companies Incorporated  0.62 $ 546.700  Millions$ 880.300  Millions
Align Technology inc   0.57 $ 1,144.931  Millions$ 2,002.010  Millions
Angiodynamics Inc   0.57 $ 33.973  Millions$ 59.689  Millions
Co diagnostics Inc   0.57 $ 1.430  Millions$ 2.512  Millions
Baxter International Inc   0.52 $ 1,976.000  Millions$ 3,809.000  Millions
Infusystem Holdings Inc  0.51 $ 9.108  Millions$ 17.873  Millions
Stryker Corp  0.50 $ 3,271.000  Millions$ 6,500.000  Millions
Msa Safety Inc  0.50 $ 187.248  Millions$ 373.698  Millions
Teleflex Incorporated  0.50 $ 454.065  Millions$ 917.102  Millions
Sonoma Pharmaceuticals Inc   0.46 $ 4.609  Millions$ 9.944  Millions
P3 Health Partners Inc   0.46 $ 43.900  Millions$ 95.593  Millions
Avita Medical Inc   0.46 $ 10.500  Millions$ 23.037  Millions
Alphatec Holdings Inc   0.44 $ 79.936  Millions$ 180.767  Millions
Steris Plc  0.44 $ 531.100  Millions$ 1,207.800  Millions
Sanuwave Health Inc   0.40 $ 6.569  Millions$ 16.394  Millions
Novocure Limited  0.38 $ 102.738  Millions$ 270.659  Millions
Cadre Holdings inc   0.36 $ 63.916  Millions$ 178.051  Millions
U S Physical Therapy Inc  0.35 $ 38.225  Millions$ 109.218  Millions
Tela Bio Inc   0.31 $ 22.664  Millions$ 73.706  Millions
Tandem Diabetes Care Inc   0.28 $ 72.840  Millions$ 256.075  Millions
Ufp Technologies Inc   0.27 $ 20.625  Millions$ 77.359  Millions
Docgo Inc   0.26 $ 20.569  Millions$ 79.655  Millions
Bausch and Lomb Corp  0.25 $ 513.000  Millions$ 2,019.000  Millions
Accuray Incorporated  0.25 $ 42.254  Millions$ 170.106  Millions

Date modified: 2026-10-29T17:23:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.